Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Anika Therapeutics (ANIK) Return on Assets: 2011-2024

Historic Return on Assets for Anika Therapeutics (ANIK) over the last 14 years, with Dec 2024 value amounting to -0.20%.

  • Anika Therapeutics' Return on Assets fell 5.00% to -0.10% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.10%, marking a year-over-year decrease of 5.00%. This contributed to the annual value of -0.20% for FY2024, which is 5.00% up from last year.
  • According to the latest figures from FY2024, Anika Therapeutics' Return on Assets is -0.20%, which was up 21.41% from -0.26% recorded in FY2023.
  • Over the past 5 years, Anika Therapeutics' Return on Assets peaked at 0.02% during FY2021, and registered a low of -0.26% during FY2023.
  • In the last 3 years, Anika Therapeutics' Return on Assets had a median value of -0.20% in 2024 and averaged -0.17%.
  • As far as peak fluctuations go, Anika Therapeutics' Return on Assets increased by 9bps in 2021, and later declined by 21bps in 2023.
  • Anika Therapeutics' Return on Assets (Yearly) stood at -0.07% in 2020, then increased by 9bps to 0.02% in 2021, then fell by 7bps to -0.05% in 2022, then dropped by 21bps to -0.26% in 2023, then rose by 5bps to -0.20% in 2024.